ANO1 and breast cancer: Previous investigations from others and ours have shown that ANO1 is amplified or overexpressed in various cancers including head and neck squamous cell carcinoma (HNSCC), prostate cancer, breast cancer, colon cancer and lung adenocarcinoma, making it a promising tumor marker [18, 19, 23].